Randomized cross-over trial comparing inpatient and outpatient administration of high-dose cisplatin
Author:
Publisher
Wiley
Subject
Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1445-5994.2010.02201.x/fullpdf
Reference17 articles.
1. Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin;Kris;J Clin Oncol,1985
2. Platinum nephrotoxicity;Madias;Am J Med,1978
3. The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin - the Aprepitant Protocol 052 Study Group;Hesketh;J Clin Oncol,2003
4. High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis;Hayes;Cancer,1977
5. Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients;de Jongh;Br J Cancer,2003
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Outpatient consolidation chemotherapy with intermediate dose cytarabine has similar survival and relapses rates in acute myeloid leukemia as compared to high dose cytarabine: A single center analysis;European Journal of Haematology;2023-08-28
2. Patients' preference regarding inpatient versus outpatient setting ‐ A systematic review;The International Journal of Health Planning and Management;2023-06-09
3. Reducing Hospitalizations: Institution of Outpatient Infusional EPOCH-Based Chemotherapy at a Safety Net Hospital;Journal of Oncology Practice;2019-08
4. Making moves: Transitioning R-EPOCH to the ambulatory setting;Journal of Oncology Pharmacy Practice;2017-08-07
5. A Study of the Protective Effect of Oral Rehydration Solution on Cisplatin-induced Nephrotoxicity in Rats;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3